ANDREW GUGGENHIME
CIK 1230724 · PRESIDENT AND CFO · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.53M
Companies
6
Total Filings
104
Lifetime Open-Market Net
-$20.14M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCVX | PRESIDENT AND CFO | 168,332 | $58.89 | $9.91M | -$18.16M | 48 | 2026-07-06 |
| CRBU | Director | — | $1.64 | — | $0 | 5 | 2026-02-20 |
| Metacrine, Inc. (MTCR) Delisted | Director | — | $0.49 | — | $0 | 2 | 2022-09-06 |
| DERM | CFO | 42,159 | $6.53 | $275.3K | -$1.98M | 15 | 2019-08-19 |
| FACT | SVP & CFO | 32,090 | $10.67 | $342.4K | $0 | 5 | 2010-04-21 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | SVP & Chief Financial Officer | 13,255 | — | — | $0 | 5 | 2008-12-19 |
Recent Filings · Page 5 of 11
104 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-18 | PCVX | Notice (144) | −8,000 | -$549.3K | EDGAR |
| 2024-03-04 | PCVX | Mixed | +16,205 | -$271.5K | EDGAR |
| 2024-02-22 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2024-02-22 | PCVX | Mixed | — | -$553.4K | EDGAR |
| 2024-02-20 | PCVX | Notice (144) | −8,000 | -$595.2K | EDGAR |
| 2024-01-19 | PCVX | Mixed | — | -$443.1K | EDGAR |
| 2024-01-18 | PCVX | Notice (144) | −8,000 | -$506.8K | EDGAR |
| 2023-12-20 | PCVX | Mixed | — | -$438.6K | EDGAR |
| 2023-12-18 | PCVX | Notice (144) | −8,000 | -$482.4K | EDGAR |
| 2023-12-18 | PCVX | Mixed | — | -$768.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.